Silicon Valley Capital Partners

Position in PFE — Pfizer Inc

CIK 1673633 SAN JOSE, CA

Position in PFE

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$207,707

+$24,394 QoQ

Shares Held

7,397

+0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Silicon Valley Capital Partners holds $14,966,250 across 12 Drug Manufacturers - General names. PFE ranks #3 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,009	$11,965,287
2	JNJ	Johnson & Johnson	9,659	$2,361,045
3	PFE	Pfizer Inc This page	7,397	$207,707
4	AMGN	Amgen Inc	487	$171,350
5	ABBV	AbbVie Inc.	580	$126,144
6	BMY	Bristol Myers Squibb Co	1,154	$69,990
7	MRK	Merck & Co., Inc.	380	$45,710
8	NVO	Novo Nordisk A S	276	$10,143

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$207,707	7,397	+0.5%	Shares	Sole	2026-05-19
2025-12-31	$183,313	7,362	-19.1%	Shares	Sole	2026-02-13
2025-09-30	$231,893	9,101	-33.1%	Shares	Sole	2025-11-17
2025-06-30	$329,615	13,598	-7.8%	Shares	Sole	2025-09-11
2025-03-31	$373,815	14,752	+0.7%	Shares	Sole	2025-05-28
2024-12-31	$388,505	14,644	+0.7%	Shares	Sole	2025-01-29
2024-09-30	$420,787	14,540	+0.6%	Shares	Sole	2024-10-30
2024-06-30	$404,255	14,448	+587.0%	Shares	Sole	2024-10-30
2024-03-31	$58,358	2,103	+1.5%	Shares	Sole	2024-04-29
2023-12-31	$59,624	2,071	+1.3%	Shares	Sole	2024-02-14
2023-09-30	$67,799	2,044	+1.2%	Shares	Sole	2023-11-06
2023-06-30	$74,093	2,020	+1.1%	Shares	Sole	2023-08-14
2023-03-31	$81,559	1,999	+1.0%	Shares	Sole	2023-05-10
2022-12-31	$101,403	1,979	-49.0%	Shares	Sole	2023-02-14
2021-12-31	$228,936	3,877	-29.8%	Shares	Sole	2022-02-11
2021-03-31	$200,098	5,523	-12.2%	Shares	Sole	2021-05-10
2020-12-31	$231,645	6,293	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.